Cargando…

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study

PURPOSE: The ‘treatable traits’ strategy for patients with chronic inflammatory airway diseases, especially asthma and chronic obstructive pulmonary disease (COPD), is a focus of interest, because it implements precision and personalized medicine. Asthma-COPD overlap (ACO), a phenotype involving bot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishiura, Yoshihisa, Fujimura, Masaki, Ohkura, Noriyuki, Hara, Johsuke, Nakahama, Kahori, Sawai, Yusuke, Tamaki, Takeshi, Murai, Ryuta, Shimizu, Toshiki, Miyashita, Naoyuki, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148922/ https://www.ncbi.nlm.nih.gov/pubmed/35651483 http://dx.doi.org/10.2147/JAA.S360260

Ejemplares similares

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
por: Ishiura, Yoshihisa, et al.
Publicado: (2020)

Effect of triple therapy in patients with asthma-COPD overlap
por: Ishiura, Yoshihisa, et al.
Publicado: (2019)

Efficacy of gefapixant, a P2X(3) antagonist, for lung cancer-related cough: a case report
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Efficacy of Gefapixant, a P2X(3) Antagonist, for Refractory Atopic Cough
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

A warning related to predicting the severity of COVID-19 pneumonia using the A-DROP scoring system
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical features of nursing and healthcare-associated pneumonia due to COVID-19
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis
por: Ishii, Nobuyasu, et al.
Publicado: (2021)

Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome
por: Ishiura, Yoshihisa, et al.
Publicado: (2010)

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
por: Nakaya, Aya, et al.
Publicado: (2019)

Effect of add-on therapy of tiotropium in COPD treated with theophylline
por: Kawayama, Tomotaka, et al.
Publicado: (2008)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience
por: Vogelberg, Christian
Publicado: (2016)

Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients
por: Zielen, Stefan, et al.
Publicado: (2021)

Comparison of cough reflex sensitivity after an inhaled antigen challenge between actively and passively sensitized guinea pigs
por: Hara, Johsuke, et al.
Publicado: (2005)

Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients
por: Vogelberg, Christian, et al.
Publicado: (2019)

Bronchodilator effect of deep inspiration and bronchoconstriction-triggered cough
por: Ohkura, Noriyuki, et al.
Publicado: (2009)

Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
por: Mark FitzGerald, J., et al.
Publicado: (2020)

Asthma-COPD Overlap in Two Comprehensive Cohorts in Korea: Time to Move to Treatable Traits
por: Sohn, Kyoung-Hee
Publicado: (2022)

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature
por: INAGAKI, NORIKO, et al.
Publicado: (2013)

Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19
por: Miyashita, Naoyuki, et al.
Publicado: (2023)

Platelet-Derived Microparticles are an Important Biomarker in Patients with Cancer-Associated Thrombosis
por: Yamanaka, Yuta, et al.
Publicado: (2019)

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients
por: Sawai, Yusuke, et al.
Publicado: (2020)

Tiotropium bromide
por: Lipson, David A
Publicado: (2006)

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy
por: KIBATA, KAYOKO, et al.
Publicado: (2013)

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer
por: SHIMIZU, TOSHIKI, et al.
Publicado: (2013)

Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections
por: Miyashita, Naoyuki, et al.
Publicado: (2023)

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
por: Price, David, et al.
Publicado: (2015)

Tiotropium respimat(®) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status
por: Yang, WH, et al.
Publicado: (2014)

Add-on Tiotropium in Chinese Patients With Moderate Asthma: A Pooled Subgroup Analysis of MezzoTinA-Asthma 1 and 2
por: Lin, Jiangtao, et al.
Publicado: (2019)

Tiotropium Bromide: An Update
por: Heredia, Josep Lluis
Publicado: (2009)

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment
por: Kimura, Hideharu, et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease
por: Hohlfeld, JM, et al.
Publicado: (2014)

Treatable Mechanisms in Asthma
por: Cazzola, Mario, et al.
Publicado: (2021)

Treatable cerebellar ataxias()
por: K.P., Divya, et al.
Publicado: (2020)

Burden of Asthma and Role of 2.5 µg Tiotropium Respimat(®) as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials
por: Mansfield, Lyndon, et al.
Publicado: (2019)

Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
por: Shim, Ji-Su, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mg20aud0fb5c2q0s0fdtsl6qdo